Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The daily Top 10 COVID papers


  Breast Cancer

  Free Subscription


21.12.2020

1 AJR Am J Roentgenol
2 Am J Pathol
2 Am J Surg
2 BMC Cancer
1 BMJ
1 Breast Cancer (Auckl)
1 Breast Cancer (Dove Med Press)
2 Breast Cancer Res Treat
2 Breast J
3 Cancer
1 Cancer Lett
3 Clin Breast Cancer
4 Clin Cancer Res
1 Eur J Surg Oncol
2 Eur Radiol
1 Int J Cancer
4 Int J Radiat Oncol Biol Phys
1 J Biol Chem
1 J Clin Invest
5 J Clin Oncol
1 J Natl Cancer Inst
3 J Surg Oncol
1 Lancet Oncol
1 Nat Rev Cancer
3 Nature
1 NPJ Breast Cancer
3 Oncogene
1 PLoS Comput Biol
4 PLoS One
3 Proc Natl Acad Sci U S A
4 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. POLAT DS, Evans WP, Dogan BE
    Contrast-Enhanced Digital Mammography: Technique, Clinical Applications, and Pitfalls.
    AJR Am J Roentgenol. 2020 Sep 2:1-12. doi: 10.2214/AJR.19.22412.
    PubMed         Abstract available


    Am J Pathol

  2. LU N, Zhang M, Lu L, Liu YZ, et al
    Insulin-Induced Gene 2 Expression Is Associated with Breast Cancer Metastasis.
    Am J Pathol. 2020 Dec 13. pii: S0002-9440(20)30555.
    PubMed         Abstract available

  3. LOPEZ C, Gibert-Ramos A, Bosch R, Korzynska A, et al
    Differences in the immune response of the non-metastatic axillary lymph nodes between triple-negative and luminal A breast cancer surrogate subtypes.
    Am J Pathol. 2020 Dec 9. pii: S0002-9440(20)30549.
    PubMed         Abstract available


    Am J Surg

  4. THOMPSON JL, Wright GP
    The role of breast MRI in newly diagnosed breast cancer: An evidence-based review.
    Am J Surg. 2020 Dec 9. pii: S0002-9610(20)30796.
    PubMed         Abstract available

  5. COLLINS PM, Brennan MJ, Elliott JA, Abd Elwahab S, et al
    Neoadjuvant chemotherapy for luminal a breast cancer: Factors predictive of histopathologic response and oncologic outcome.
    Am J Surg. 2020 Dec 9. pii: S0002-9610(20)30776.
    PubMed         Abstract available


    BMC Cancer

  6. EGELAND NG, Jonsdottir K, Aure MR, Sahlberg K, et al
    MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers.
    BMC Cancer. 2020;20:377.
    PubMed         Abstract available

  7. WATANABE K, Katayama K, Yoshioka T, Narimatsu H, et al
    Impact of individual background on the unmet needs of cancer survivors and caregivers - a mixed-methods analysis.
    BMC Cancer. 2020;20:263.
    PubMed         Abstract available


    BMJ

  8. CHIN YR, Warner R
    Diffuse bruising on left breast.
    BMJ. 2020;371:m4179.
    PubMed        


    Breast Cancer (Auckl)

  9. OLTRA SS, Pena-Chilet M, Martinez MT, Tormo E, et al
    miRNA Expression Analysis: Cell Lines HCC1500 and HCC1937 as Models for Breast Cancer in Young Women and the miR-23a as a Poor Prognostic Biomarker.
    Breast Cancer (Auckl). 2020;14:1178223420977845.
    PubMed         Abstract available


    Breast Cancer (Dove Med Press)

  10. WU J, Luo D, Li S
    Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer.
    Breast Cancer (Dove Med Press). 2020;12:267-277.
    PubMed         Abstract available


    Breast Cancer Res Treat

  11. YARDLEY DA, Peacock N, Daniel B, Anz B, et al
    Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy.
    Breast Cancer Res Treat. 2020;180:647-655.
    PubMed         Abstract available

  12. JENNARO TS, Fang F, Kidwell KM, Smith EML, et al
    Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy.
    Breast Cancer Res Treat. 2020;180:707-714.
    PubMed         Abstract available


    Breast J

  13. COLLADO-MESA F, Kaplan SS, Yepes MM, Thurber MJ, et al
    Impact of COVID-19 on breast imaging case volumes in South Florida: A multicenter study.
    Breast J. 2020;26:2316-2319.
    PubMed        

  14. SOOD R, Kumar S, Laroiya I, Khare S, et al
    Assessment of PD-L1 expression and tumor-infiltrating lymphocytes (TILs) across molecular subtypes of triple-negative breast cancer.
    Breast J. 2020 Dec 14. doi: 10.1111/tbj.14110.
    PubMed        


    Cancer

  15. SHAO D, Zhang H, Cui N, Sun J, et al
    The efficacy and mechanisms of a guided self-help intervention based on mindfulness in patients with breast cancer: A randomized controlled trial.
    Cancer. 2020 Dec 17. doi: 10.1002/cncr.33381.
    PubMed         Abstract available

  16. SEAH DS, Leone JP, Openshaw TH, Scott SM, et al
    Perceptions of patients with early stage breast cancer toward research biopsies.
    Cancer. 2020 Dec 15. doi: 10.1002/cncr.33371.
    PubMed         Abstract available

  17. YIN K, Singh P, Drohan B, Hughes KS, et al
    Breast imaging, breast surgery, and cancer genetics in the age of COVID-19.
    Cancer. 2020;126:4466-4472.
    PubMed         Abstract available


    Cancer Lett

  18. MAVINGIRE N, Campbell P, Wooten J, Aja J, et al
    Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes.
    Cancer Lett. 2020 Dec 9. pii: S0304-3835(20)30664.
    PubMed         Abstract available


    Clin Breast Cancer

  19. FAHIM HH, Mohamed G, Safwat G, Abo-Bakr A, et al
    HSP70 as a Diagnostic and Prognostic Marker in Egyptian Women With Breast Cancer.
    Clin Breast Cancer. 2020 Nov 13. pii: S1526-8209(20)30289.
    PubMed         Abstract available

  20. GILBERT A, Williams C, Azuero A, Burkard ME, et al
    Utilizing Data Visualization to Identify Survival and Treatment Differences Between Women With De Novo and Recurrent Metastatic Breast Cancer.
    Clin Breast Cancer. 2020 Nov 17. pii: S1526-8209(20)30293.
    PubMed         Abstract available

  21. SHATNAWI A, Ayoub NM, Alkhalifa AE
    ING4 Expression Landscape and Association With Clinicopathologic Characteristics in Breast Cancer.
    Clin Breast Cancer. 2020 Nov 19. pii: S1526-8209(20)30295.
    PubMed         Abstract available


    Clin Cancer Res

  22. COLLIN LJ, Cronin-Fenton D, Ahern TP, Goodman M, et al
    Early discontinuation of endocrine therapy and recurrence of breast cancer among premenopausal women.
    Clin Cancer Res. 2020 Dec 17. pii: 1078-0432.CCR-20-3974.
    PubMed         Abstract available

  23. BUUS R, Sestak I, Barron S, Loughman T, et al
    Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC study.
    Clin Cancer Res. 2020;26:623-631.
    PubMed         Abstract available

  24. HICKS KC, Knudson KM, Lee KL, Hamilton DH, et al
    Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy.
    Clin Cancer Res. 2020;26:704-716.
    PubMed         Abstract available

  25. JACOB S, Davis AA, Gerratana L, Velimirovic M, et al
    The use of serial circulating tumor DNA (ctDNA) to detect resistance alterations in progressive metastatic breast cancer.
    Clin Cancer Res. 2020 Dec 15. pii: 1078-0432.CCR-20-1566.
    PubMed         Abstract available


    Eur J Surg Oncol

  26. GHILLI M, Mariniello MD, Camilleri V, Murante AM, et al
    PROMs in post-mastectomy care: Patient self-reports (BREAST-Q) as a powerful instrument to personalize medical services.
    Eur J Surg Oncol. 2020;46:1034-1040.
    PubMed         Abstract available


    Eur Radiol

  27. DE JONG L, Welleweerd MK, van Zelst JCM, Siepel FJ, et al
    Production and clinical evaluation of breast lesion skin markers for automated three-dimensional ultrasonography of the breast: a pilot study.
    Eur Radiol. 2020;30:3356-3362.
    PubMed         Abstract available

  28. SODANO C, Clauser P, Dietzel M, Kapetas P, et al
    Clinical relevance of total choline (tCho) quantification in suspicious lesions on multiparametric breast MRI.
    Eur Radiol. 2020;30:3371-3382.
    PubMed         Abstract available


    Int J Cancer

  29. MUPPALA S, Xiao R, Gajeton J, Krukovets I, et al
    Thrombospondin-4 mediates hyperglycemia- and TGF-beta-induced inflammation in breast cancer.
    Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33439.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  30. VASMEL JE, Vreuls CP, Manson QF, Charaghvandi RK, et al
    Tumor infiltrating lymphocytes in low-risk breast cancer patients treated with single dose pre-operative partial breast irradiation.
    Int J Radiat Oncol Biol Phys. 2020 Dec 14. pii: S0360-3016(20)34655.
    PubMed         Abstract available

  31. CLASEN SC, Shou H, Freedman G, Plastaras JP, et al
    Early cardiac effects of contemporary radiation therapy in breast cancer patients.
    Int J Radiat Oncol Biol Phys. 2020 Dec 16. pii: S0360-3016(20)34654.
    PubMed         Abstract available


  32. Erratum to: Sperduto PW, Mesko S, Li J, et al. Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today. Int J Radiat Oncol Biol Phys 2020
    Int J Radiat Oncol Biol Phys. 2021;109:303.
    PubMed        

  33. HORNER-RIEBER J, Forster T, Hommertgen A, Haefner MF, et al
    Intensity-modulated radiotherapy (IMRT) with simultaneously integrated boost shortens treatment time and is non-inferior to conventional radiotherapy followed by sequential boost in adjuvant breast cancer treatment: results of a large randomized phase
    Int J Radiat Oncol Biol Phys. 2020 Dec 12. pii: S0360-3016(20)34651.
    PubMed         Abstract available


    J Biol Chem

  34. HARTMAN Z, Geldenhuys WJ, Agazie YM
    A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2).
    J Biol Chem. 2020;295:3563-3575.
    PubMed         Abstract available


    J Clin Invest

  35. EDWARDS DN, Ngwa VM, Raybuck AL, Wang S, et al
    Selective glutamine metabolism inhibition in tumor cells improves anti-tumor T lymphocyte activity in triple-negative breast cancer.
    J Clin Invest. 2020 Dec 15. pii: 140100. doi: 10.1172/JCI140100.
    PubMed         Abstract available


    J Clin Oncol

  36. LAZZERONI M, DeCensi A
    De-Escalating Treatment of Low-Risk Breast Ductal Carcinoma In Situ.
    J Clin Oncol. 2020;38:1252-1254.
    PubMed        

  37. YANG X, Leslie G, Doroszuk A, Schneider S, et al
    Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
    J Clin Oncol. 2020;38:674-685.
    PubMed         Abstract available

  38. MO DC, Luo PH, Huang JF, Huang SX, et al
    Neratinib Plus Capecibine in Patients With HER2-Positive Metastatic Breast Cancer.
    J Clin Oncol. 2020 Dec 17:JCO2002378. doi: 10.1200/JCO.20.02378.
    PubMed        

  39. DOWSETT M, Sestak I, Cuzick J
    Calibration of CTS5 in Women With Early Estrogen Receptor-Positive Breast Cancer.
    J Clin Oncol. 2020 Dec 16:JCO2002551. doi: 10.1200/JCO.20.02551.
    PubMed        

  40. DEKKER TJA
    Neratinib in HER2-Positive Breast Cancer With Brain Metastases.
    J Clin Oncol. 2020 Dec 17:JCO2002385. doi: 10.1200/JCO.20.02385.
    PubMed        


    J Natl Cancer Inst

  41. LIN CH, Yap YS, Lee KH, Yeo W, et al
    Response to Sung, Rosenberg, and Yang.
    J Natl Cancer Inst. 2020;112:547-548.
    PubMed        


    J Surg Oncol

  42. SONAGLI M, Cagnacci Neto R, Leite FPM, Makdissi FBA, et al
    The use of telemedicine to maintain breast cancer follow-up and surveillance during the COVID-19 pandemic.
    J Surg Oncol. 2020 Dec 17. doi: 10.1002/jso.26327.
    PubMed         Abstract available

  43. CORONEOS CJ, Woodward WA, Wong FC, Caudle AS, et al
    Anatomy and physiology of the sentinel lymph nodes of the upper extremity: Implications for axillary reverse mapping in breast cancer.
    J Surg Oncol. 2020 Dec 17. doi: 10.1002/jso.26343.
    PubMed         Abstract available

  44. KHADER A, Chang SC, Santamaria-Barria J, Garland-Kledzik M, et al
    Delay in surgery is associated with axillary upstaging of clinically node negative breast cancer patients.
    J Surg Oncol. 2020 Dec 17. doi: 10.1002/jso.26332.
    PubMed         Abstract available


    Lancet Oncol

  45. BISWAS D, Ganeshalingam J, Wan JCM
    The future of liquid biopsy.
    Lancet Oncol. 2020;21:e550.
    PubMed        


    Nat Rev Cancer

  46. SETON-ROGERS S
    Cardiovascular disease and cancer communicate.
    Nat Rev Cancer. 2020;20:552.
    PubMed        


    Nature

  47. TAVORA B, Mederer T, Wessel KJ, Ruffing S, et al
    Tumoural activation of TLR3-SLIT2 axis in endothelium drives metastasis.
    Nature. 2020;586:299-304.
    PubMed         Abstract available

  48. HERNANSANZ-AGUSTIN P, Choya-Foces C, Carregal-Romero S, Ramos E, et al
    Na(+) controls hypoxic signalling by the mitochondrial respiratory chain.
    Nature. 2020;586:287-291.
    PubMed         Abstract available

  49. MEITINGER F, Ohta M, Lee KY, Watanabe S, et al
    TRIM37 controls cancer-specific vulnerability to PLK4 inhibition.
    Nature. 2020;585:440-446.
    PubMed         Abstract available


    NPJ Breast Cancer

  50. BOHLOK A, Vermeulen P, Leduc S, Latacz E, et al
    Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients.
    NPJ Breast Cancer. 2020;6:64.
    PubMed         Abstract available


    Oncogene

  51. PANCHOLI S, Ribas R, Simigdala N, Schuster E, et al
    Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities.
    Oncogene. 2020;39:4781-4797.
    PubMed         Abstract available

  52. WANG S, Somisetty VS, Bai B, Chernukhin I, et al
    The proapoptotic gene interferon regulatory factor-1 mediates the antiproliferative outcome of paired box 2 gene and tamoxifen.
    Oncogene. 2020;39:6300-6312.
    PubMed         Abstract available

  53. WANG M, Long K, Li E, Li L, et al
    DNA polymerase beta modulates cancer progression via enhancing CDH13 expression by promoter demethylation.
    Oncogene. 2020;39:5507-5519.
    PubMed         Abstract available


    PLoS Comput Biol

  54. VAN DER KLOET FM, Buurmans J, Jonker MJ, Smilde AK, et al
    Increased comparability between RNA-Seq and microarray data by utilization of gene sets.
    PLoS Comput Biol. 2020;16:e1008295.
    PubMed         Abstract available


    PLoS One

  55. LI X, Plataniotis KN
    How much off-the-shelf knowledge is transferable from natural images to pathology images?
    PLoS One. 2020;15:e0240530.
    PubMed         Abstract available

  56. MOGAKA JJO, Chimbari MJ
    The mediating effects of public genomic knowledge in precision medicine implementation: A structural equation model approach.
    PLoS One. 2020;15:e0240585.
    PubMed         Abstract available

  57. MOODLEY J, Constant D, Mwaka AD, Scott SE, et al
    Mapping awareness of breast and cervical cancer risk factors, symptoms and lay beliefs in Uganda and South Africa.
    PLoS One. 2020;15:e0240788.
    PubMed         Abstract available

  58. BAR-SELA G, Cohen I, Avisar A, Loven D, et al
    Circulating blood extracellular vesicles as a tool to assess endothelial injury and chemotherapy toxicity in adjuvant cancer patients.
    PLoS One. 2020;15:e0240994.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  59. SPANGLE JM, Von T, Pavlick DC, Khotimsky A, et al
    PIK3CA C-terminal frameshift mutations are novel oncogenic events that sensitize tumors to PI3K-alpha inhibition.
    Proc Natl Acad Sci U S A. 2020;117:24427-24433.
    PubMed         Abstract available

  60. PRATT SJP, Lee RM, Chang KT, Hernandez-Ochoa EO, et al
    Mechanoactivation of NOX2-generated ROS elicits persistent TRPM8 Ca(2+) signals that are inhibited by oncogenic KRas.
    Proc Natl Acad Sci U S A. 2020;117:26008-26019.
    PubMed         Abstract available

  61. XUAN B, Ghosh D, Jiang J, Shao R, et al
    Vimentin filaments drive migratory persistence in polyploidal cancer cells.
    Proc Natl Acad Sci U S A. 2020;117:26756-26765.
    PubMed         Abstract available


    Radiology

  62. BERG WA, Berg JM, Sickles EA, Burnside ES, et al
    Cancer Yield and Patterns of Follow-up for BI-RADS Category 3 after Screening Mammography Recall in the National Mammography Database.
    Radiology. 2020 May 19:192641. doi: 10.1148/radiol.2020192641.
    PubMed         Abstract available

  63. MOY L
    BI-RADS Category 3 Is a Safe and Effective Alternative to Biopsy or Surgical Excision.
    Radiology. 2020;296:42-43.
    PubMed        

  64. SALIM M, Dembrower K, Eklund M, Lindholm P, et al
    Range of Radiologist Performance in a Population-based Screening Cohort of 1 Million Digital Mammography Examinations.
    Radiology. 2020 Jul 28:192212. doi: 10.1148/radiol.2020192212.
    PubMed         Abstract available

  65. BROWN AL, Wahab RA
    MRI of Primary Angiosarcoma of the Breast.
    Radiology. 2020 Jul 28:201377. doi: 10.1148/radiol.2020201377.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: